SI8810183A8 - Postopek za pridobivanje kristalne natrijeve soli 5-klor-3-(2-tenoil)-2-oksindol-1-karboksamida - Google Patents

Postopek za pridobivanje kristalne natrijeve soli 5-klor-3-(2-tenoil)-2-oksindol-1-karboksamida Download PDF

Info

Publication number
SI8810183A8
SI8810183A8 SI8810183A SI8810183A SI8810183A8 SI 8810183 A8 SI8810183 A8 SI 8810183A8 SI 8810183 A SI8810183 A SI 8810183A SI 8810183 A SI8810183 A SI 8810183A SI 8810183 A8 SI8810183 A8 SI 8810183A8
Authority
SI
Slovenia
Prior art keywords
carboxamide
oxindole
chloro
thenoyl
sodium salt
Prior art date
Application number
SI8810183A
Other languages
English (en)
Slovenian (sl)
Inventor
Douglas John Meldrum Allen
Brian Thomas O'neill
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SI8810183A8 publication Critical patent/SI8810183A8/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI8810183A 1987-02-02 1988-02-01 Postopek za pridobivanje kristalne natrijeve soli 5-klor-3-(2-tenoil)-2-oksindol-1-karboksamida SI8810183A8 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1987/000201 WO1988005656A1 (en) 1987-02-02 1987-02-02 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
YU18388A YU46766B (sh) 1987-02-02 1988-02-01 Postupak za dobijanje anhidrovane, kristalne natrijumove soli 5-hlor-3-(2-tenoil)-2-ok-sindol-1-karboksamida

Publications (1)

Publication Number Publication Date
SI8810183A8 true SI8810183A8 (sl) 1996-08-31

Family

ID=22202263

Family Applications (1)

Application Number Title Priority Date Filing Date
SI8810183A SI8810183A8 (sl) 1987-02-02 1988-02-01 Postopek za pridobivanje kristalne natrijeve soli 5-klor-3-(2-tenoil)-2-oksindol-1-karboksamida

Country Status (42)

Country Link
US (1) US5036099A (is)
EP (1) EP0277738B1 (is)
JP (1) JPS63201184A (is)
KR (1) KR900001422B1 (is)
CN (1) CN1022324C (is)
AP (1) AP52A (is)
AR (1) AR243182A1 (is)
AT (1) ATE73800T1 (is)
AU (1) AU587736B2 (is)
BG (1) BG51042A3 (is)
CA (1) CA1335590C (is)
CS (2) CS265250B2 (is)
CY (1) CY1775A (is)
DD (1) DD267490A5 (is)
DE (1) DE3869149D1 (is)
DK (1) DK44888A (is)
EC (1) ECSP941082A (is)
ES (1) ES2032955T3 (is)
FI (1) FI89598C (is)
GR (1) GR3004200T3 (is)
HK (1) HK132695A (is)
IE (1) IE60000B1 (is)
IL (1) IL85277A (is)
IN (1) IN171799B (is)
IS (1) IS1533B (is)
LV (1) LV10252B (is)
MA (1) MA21171A1 (is)
MY (1) MY102737A (is)
NO (1) NO170581C (is)
NZ (1) NZ223373A (is)
OA (1) OA08710A (is)
PH (1) PH26545A (is)
PL (1) PL149550B1 (is)
PT (1) PT86675B (is)
RO (1) RO105052B1 (is)
RU (1) RU2011381C1 (is)
SG (1) SG27994G (is)
SI (1) SI8810183A8 (is)
UA (1) UA25898A1 (is)
WO (1) WO1988005656A1 (is)
YU (1) YU46766B (is)
ZA (1) ZA88679B (is)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
DE68923673T2 (de) * 1988-10-18 1996-01-18 Pfizer Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden.
SK590689A3 (en) * 1988-10-18 1996-03-06 Pfizer 3-aryl-2-oxindole-1-carboxamides and method of their preparation
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
WO1997022605A1 (en) * 1995-12-19 1997-06-26 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US7407195B2 (en) 2004-04-14 2008-08-05 William Berson Label for receiving indicia having variable spectral emissivity values
US7651031B2 (en) 2004-10-25 2010-01-26 William Berson Systems and methods for reading indicium
US7728726B2 (en) * 2005-01-14 2010-06-01 William Berson Radio frequency identification labels
US7931413B2 (en) * 2005-01-14 2011-04-26 William Berson Printing system ribbon including print transferable circuitry and elements
US7619520B2 (en) * 2005-01-14 2009-11-17 William Berson Radio frequency identification labels and systems and methods for making the same
US7621451B2 (en) * 2005-01-14 2009-11-24 William Berson Radio frequency identification labels and systems and methods for making the same
KR20200085285A (ko) 2017-11-02 2020-07-14 애커러트 메디컬 테라퓨틱스 엘티디. 필터가 내장된 색전술용 카테터

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
DE2613346C3 (de) * 1976-03-29 1981-07-23 Diamalt AG, 8000 München Monoklin kristalline Chenodesoxycholsäure und Verfahren zu ihrer Herstellung
ATE63543T1 (de) * 1984-02-07 1991-06-15 Pfizer 2-oxindolzwischenprodukte.
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
DE3579716D1 (de) * 1984-03-19 1990-10-25 Pfizer Verfahren zur herstellung von 2-oxindole-1-carboxamiden und deren zwischenprodukte.
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
AP8800081A0 (en) 1987-11-01
FI893647A0 (fi) 1989-08-01
JPH0576945B2 (is) 1993-10-25
IE880269L (en) 1988-08-02
CS354191A3 (en) 1992-04-15
ZA88679B (en) 1989-09-27
AR243182A1 (es) 1993-07-30
IS3309A7 (is) 1988-08-03
UA25898A1 (uk) 1999-02-26
CA1335590C (en) 1995-05-16
PH26545A (en) 1992-08-19
CS64888A2 (en) 1988-08-16
AU1116088A (en) 1988-08-04
IL85277A (en) 1994-02-27
NO170581B (no) 1992-07-27
MY102737A (en) 1992-09-30
SG27994G (en) 1994-10-14
AP52A (en) 1989-09-16
IS1533B (is) 1994-01-28
EP0277738B1 (en) 1992-03-18
CN1022324C (zh) 1993-10-06
RO105052B1 (en) 1994-12-01
BG51042A3 (en) 1993-01-15
YU18388A (en) 1989-10-31
NO884329L (no) 1988-09-29
KR880009961A (ko) 1988-10-06
YU46766B (sh) 1994-05-10
PL149550B1 (en) 1990-02-28
DK44888A (da) 1988-08-03
DD267490A5 (de) 1989-05-03
AU587736B2 (en) 1989-08-24
MA21171A1 (fr) 1988-10-01
IN171799B (is) 1993-01-09
IL85277A0 (en) 1988-07-31
KR900001422B1 (ko) 1990-03-09
PT86675A (pt) 1988-03-01
PT86675B (pt) 1992-07-31
OA08710A (fr) 1989-03-31
DK44888D0 (da) 1988-01-29
JPS63201184A (ja) 1988-08-19
LV10252B (en) 1995-04-20
GR3004200T3 (is) 1993-03-31
ES2032955T3 (es) 1996-07-16
CY1775A (en) 1996-04-05
FI89598B (fi) 1993-07-15
PL270415A1 (en) 1988-12-08
CN88100555A (zh) 1988-08-17
EP0277738A1 (en) 1988-08-10
IE60000B1 (en) 1994-05-18
ECSP941082A (es) 1994-12-15
NZ223373A (en) 1989-06-28
HK132695A (en) 1995-09-01
NO884329D0 (no) 1988-09-29
ATE73800T1 (de) 1992-04-15
RU2011381C1 (ru) 1994-04-30
FI89598C (fi) 1993-10-25
LV10252A (lv) 1994-10-20
DE3869149D1 (de) 1992-04-23
CS265250B2 (en) 1989-10-13
US5036099A (en) 1991-07-30
NO170581C (no) 1992-11-04
WO1988005656A1 (en) 1988-08-11

Similar Documents

Publication Publication Date Title
SI8810183A8 (sl) Postopek za pridobivanje kristalne natrijeve soli 5-klor-3-(2-tenoil)-2-oksindol-1-karboksamida
BR0215777B1 (pt) Composition, method for preparing the same, pharmaceutical composition for preventing and treating cardioischemia, cerebrosis, cerebral arterial oclusion and for improving micro-circulation of the brain, and use of compound
JP4654187B2 (ja) テクトリゲニンのイソフラボン誘導体、その調製、および有効成分としてこれを含む抗ウィルス剤
JP7264999B2 (ja) 2-(1-アシルオキシ-n-ペンチル)安息香酸と塩基性アミノ酸またはアミノグアニジンによって形成される塩と、その製造方法及び用途
WO2015014089A1 (zh) 替格瑞洛的一水合物及其制备方法与在制药中的应用
CN111565708B (zh) 一种稳定的含有非甾体抗炎药衍生物的药物组合物
RU2485121C1 (ru) Новые кристаллические формы адефовира дипивоксила и способы его получения
CN107922448B (zh) 一种氘代噻吩并哌啶衍生物、制备方法及其应用
JP2017534635A (ja) レバプラザン塩酸塩の結晶多形及びその調製方法
FR2505834A1 (fr) Derives de la thiazolidine
TWI705065B (zh) 嗎啉衍生物的鹽及其晶型、其製備方法及藥物組成物、用途
JP4657393B2 (ja) ドキサゾシン・メシレートの新規な形態iii
CN100422133C (zh) 2-(α-羟基戊基)苯甲酸盐及其制法和用途
WO2022062401A1 (zh) 一种泰格列净的制备方法
JP2023539639A (ja) Ssao阻害剤の多形
CS195746B2 (en) Process for preparing crystalline methanolate of natrium salt of cephamandole
JPH05500205A (ja) ヘミンの精製法、新規なヘミン誘導体及びその製造方法
WO2021136491A1 (zh) 一种二肽基肽酶iv抑制剂的晶型及其制备方法和用途
JPS5910563A (ja) α−(N−ピロリル)−フエニル酢酸誘導体およびその製造方法
CZ20014270A3 (cs) Polymorfy krystalického citrátu (2-benzhydryl-1-azabicyklo[2.2.2]oct-3-yl)-(5-iso-propyl-2-methoxybenzyl)-aminu jako antagonisté receptoru NK-1
CN102731430B (zh) 非布司他的晶型和其制备方法以及应用
PT2045244E (pt) Novo cristal de ácido fenilalcanóico substituído e processo de produção
CS235223B1 (en) Method of tripiperazine dicitrean preparation
JPH0315632B2 (is)
JPS58180498A (ja) 新規アデノシン誘導体およびその製法

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20051202